Aditxt, Inc. ( (ADTX) ) has shared an announcement.
On March 12, 2025, Aditxt, Inc. announced a 1-for-250 reverse stock split, effective March 17, 2025, to comply with Nasdaq’s minimum bid price requirement. This move follows a notification from Nasdaq regarding non-compliance with listing rules, and Aditxt plans to appeal the delisting decision. The reverse stock split aims to consolidate shares and adjust stock options, ensuring continued trading under the symbol ADTX.
More about Aditxt, Inc.
Aditxt, Inc. is a social innovation platform focused on accelerating promising health innovations. It operates programs in immune health and precision health, with plans to expand into public health and women’s health. The company collaborates with research institutions, industry partners, and shareholders to drive disruptive growth and address societal challenges.
YTD Price Performance: -70.0%
Average Trading Volume: 83,917,018
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $4.73M
For detailed information about ADTX stock, go to TipRanks’ Stock Analysis page.